
Suzanne E Schindler
@SuzanneESchind1
Followers
1K
Following
3K
Media
47
Statuses
898
https://t.co/DpbtyrLAJi @WashUNeurology @WUADRC | Clinical neurologist and neuroscientist dedicated to improving the diagnosis and treatment of dementia
Saint Louis, MO, USA
Joined June 2019
RT @DrNeuroChic: Deliriously excited to share our new Neuron Perspective on transformative neuropathology—a roadmap to accelerate brain hea….
0
8
0
RT @JAMANeuro: In a specialty memory clinic, patients treated with lecanemab over 14 months experienced manageable adverse events. https://….
0
6
0
RT @ccrugom: A new study from the lab @NatureMedicine .Over 6,000 proteins, more than 10,500 individuals. #Alzheimers, #Parkinsons, and #FT….
0
58
0
RT @NeuroAmerica: CNSA's latest episode of its Alzheimer's disease 6-part series is now LIVE!. Listen to @SuzanneESchind1, MD, PhD, as she….
0
1
0
Selection and Interpretation of Biomarker Tests for Alzheimer Disease via @ReachMD @PracticalNeuro #ENDALZ @WashUNeurology.
0
3
14
RT @ALZIMPACT: The bipartisan #AADAPTAct would provide primary care physicians education and training to improve Alzheimer’s and dementia d….
0
3
0
RT @TheADDF: Today, the FDA approved an updated label for Kisunla for early-stage Alzheimer’s, with a new dosing schedule to lower ARIA ris….
0
4
0
RT @_BrightFocus: The Trump administration’s proposed 2026 budget would cut funding for the National Institutes of Health by 40% and disman….
0
1
0
RT @biofinder_study: As FDA-approved Alzheimer’s treatments reach patients, validating the ALZpath p-Tau217 assay against gold standard neu….
0
4
0
RT @Soheil_mhmdi: Following #FDA clearance of blood tests for the diagnosis of #Alzheimer’s disease, we evaluated how #obesity impacts bloo….
0
6
0
RT @DrNeuroChic: 🚨 NIH-Funded Researchers: Big Changes Starting July 1, 2025.A zero-embargo public access policy is now in effect for all N….
0
11
0
RT @TheASNR: Congratulations to the recipients of the Imaging Research in Alzheimer’s and Other Neurodegenerative Diseases grants, includin….
0
6
0
RT @alzdemjournals: Diagnosis, Assessment & Disease Monitoring Call for papers!. Real-World Evidence on Amyloid-Targeted Treatments: Early….
0
2
0
RT @SuzanneESchind1: An upcoming panel discussion on how blood biomarkers are changing testing for neurodegenerative diseases including Nic….
0
3
0
RT @ApostolovaLiana: Here is the link to the announcement of a crucially important DADM special issue - real-world experience with MAB. Ple….
0
5
0
RT @ccrugom: Around 5-10% of the #Alzheimers cases are early-onset, and are understudied. In a multiancestry genetic study of Early-onset A….
0
14
0
RT @Wilcock_v2: I wholeheartedly agree with the @alzassociation statement rebutting claims made by @HHSGov director @RFKJr_Official about t….
0
8
0
RT @DrMariaALZ: “This is just the beginning,” @BillGates wrote in a new blog post. He’s right — Alzheimer’s and dementia research has more….
0
3
0